Ertan E, Göçer P, Naycı A, Cömelekoğlu U, Atış S, Bozdağan Arpacı R, Ersöz G, Körlü S, Umit Talas D. The effect of trapidil and bevacizumab on tracheal anastomotic wound healing.
Curr Ther Res Clin Exp 2014;
75:5-7. [PMID:
24465035 PMCID:
PMC3898184 DOI:
10.1016/j.curtheres.2013.04.002]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/25/2013] [Indexed: 11/05/2022] Open
Abstract
Background
Although bevacizumab has deleterious effects on the healing of colonic anastomoses, trapidil improves wound healing of colonic and tracheal anastomoses.
Objective
We aimed to assess the effects of bevacizumab and trapidil on wound healing after tracheal transection.
Materials and methods
We evaluated 35 rats divided in 5 groups: bevacizumab (Group I, n = 7), trapidil (Group II, n = 7), trapidil + bevacizumab (Group III, n = 7), controls (Group IV, n = 7), and sham (Group V, n = 7). Anastomotic healing was assessed by measurement of bursting pressure and inflammation score at the anastomotic region on the seventh day.
Results
The bursting pressures of Group II, Group III, and Group V were significantly higher than controls (P = 0.001, P = 0.033, and P = 0.035, respectively). Fibrosis was significantly high in the sham group when compared with the other four groups (P = 0.047).
Conclusions
Although bevacizumab seems to impair anastomotic healing, trapidil can be suggested to improve tracheal anastomoses.
Collapse